Castor
Thomas Wurdinger currently serves as a member of the Board of Directors at Cellab and Omnio AB, while also being the founder of Reunion Capital, an investment fund focused on early-stage biotech start-ups. As a professor at Amsterdam UMC since February 2008, Thomas directs the neuro-oncology research group, dedicated to eradicating brain cancer. Previous roles include Head of Nucleic Acid Research at GRAIL, Inc., and Chief Scientific Officer at thromboDx. Thomas completed a PhD in Virology and Oncology at Utrecht University and holds a Master's degree in Biology from Vrije Universiteit Amsterdam.
This person is not in the org chart
Castor
1 followers
Castor provides EDC, ePRO, eCOA, eConsent, IWRS, eTMF, eSource, CDMS, and decentralized trial solutions on one platform. Tailored for medical device, biotech, pharma and academic trials. Easily capture and integrate data from multiple sources in real-t...